Introduction: The correct use of inhaler devices with facemasks and spacers in young children
Results: A total of 14 children (age range 2-7 years; 7 boys) participated in the study and used the RAFIhaler, of whom 13 completed the final survey; all 14 parents completed the survey. All 13 children reported they enjoyed playing the game. Ten of these children (91%) felt that the RAFIhaler helped them in taking their medication, and 13 of the 14 parents felt that RAFIhaler helped their
INTRODUCTION
Asthma is the commonest chronic disease of childhood and a leading cause of childhood morbidity [1] . Children may also present acutely with wheeze from other causes, such as viral infections. Studies in the UK show around a 25% prevalence of wheeze from all causes in children over a 3 year period [2] . Other European studies show that approximately one-third of all children before the age of 8 years will have required some form of inhalation therapy for wheeze [3] .
Metered dose inhalers (MDI) used with spacer devices are invaluable to allow children to gain the benefit of inhaled treatments in an effective way that can be used anywhere, without the need of nebulisers to deliver the treatments. Studies have shown that these devices, when used correctly, can match the efficacy of nebulisers for the treatment of asthmatic children [4] . Many children are also given regular inhaled preventer medication to take together with reliever inhaler medication. There is good evidence that adherence with inhalers in young children is often poor, with studies using electronic logging devices showing mean adherence rates of between 30 and 70% [5] . Inhaled treatment has its own special challenges. The treatment itself is time-consuming, especially in pre-school children. Some young children find the experience of a spacer with a close fitting face-mask frightening, which can add to the challenges faced by parents trying to administer asthma medications regularly. A good seal with the facemask is required-a poor seal greatly reduces drug delivery [6] . Drug deposition is also significantly reduced if the child is crying or screaming rather than breathing normally [6] . Asthma is a disease which is often characterised by long spells of good health interspersed by episodes of breathlessness and wheeze. For those on preventer treatments it is necessary that these treatments continue to be given throughout periods of well-being to prevent symptomatic episodes; young children may need incentives to encourage this. Those not on regular preventers only use their inhalers when unwell, and parents may find their child less co-operative at such times, just when they need the benefit of their inhaler most. The aim of this feasibility study was to develop an electronic game device using a smartphone to encourage correct use of a valved holding chamber and facemask. We assessed the response to the device from both patients and their caregivers in an acute setting.
METHODS
The Respiratory Aid For Inhalers (RAFIhaler) was developed through a period of iterative testing, design and programming. The final version assessed in this study comprises an android application installed on a smartphone, which is itself mounted on top of a valved holding chamber device ( Fig. 1 ). Each game consists of five scenes which can be completed with five good breaths.
The initial prototype was developed by a father (TA) for his son (Rafi) who was very difficult to manage acutely because of intolerance to his prescribed spacer. Although the final device could be useful in chronic care, the current feasibility study was designed to reflect this original acute setting. The final RAFIhaler was therefore tested on 14 children (age range 2-7 years) at Royal Manchester Children's Hospital who had been admitted with acute wheeze. The study had local ethical approval, and all procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964, as revised in 2013. Caregivers gave written informed consent, and children gave assent to the main study and also separately to themselves being videoed for further assessment.
Instructions on the correct breathing technique recruited by an independent researcher not involved in the device creation or direct patient care. She approached the children and their caregivers and explained the purposes of the study and explained to the children that whilst they were using their inhalers they would be able to play a game which worked as long as they 
RESULTS
Fourteen children (7 girls, 7 boys) between the ages of 2 and 7 years (median age 5 years, interquartile range 2 years) participated in the study. Thirteen children and all 14 parents completed the survey. Not all individual questions were answered, possibly because the children may have been unwilling/too shy or distracted to respond or merely had no specific comment to make.
All children stated they enjoyed playing the game. Eleven children responded to further questioning, of whom ten (91%) felt that the RAFIhaler helped them in taking medication.
One child (aged 5 years) felt that he was already good at using his inhaler but still liked playing the game.
When parents were asked if they felt that RAFIhaler helped their children use their spacer, all but one thought that it did. Interestingly, of the 13 parents who felt that the RAFIhaler helped their child in taking medication, four believed their child already had a good inhaler technique, and only three felt their child really struggled to use the inhaler.
The study used a prototype which clearly had some technical issues; the microphone displaced on occasion, the smartphone slipped a little in its support and the software needed restarting on one occasion. It was also evident that the software would require some adaptation to prevent children breathing too quickly or too hard, particularly if they became excited. The full results of the RAFIhaler survey are presented in the following subsections.
Questions To Child (Identifier Followed
by Age in Years)
1. Did you like playing?
• 13/13 respondents said yes 2. What did you like about it?
• 11 responses, all 11 expressing enjoyment of games and characters A, 5: I liked the robot. It was fun. Alliance Tech Medical Inc., Granbury, TX) has previously been shown to improve adherence over a 2-week period but not over 3 months [7, 8] . This finding reiterates the need for variety in the incentive device and the need to provide a number of games/levels, as pointed out by some of the older children in our study. A further study using the Funhaler TM did demonstrate improved spacer technique, indicating a potential benefit for such incentive devices [9] .
CONCLUSION
The results of this small preliminary study highlight a positive attitude towards the use of gaming and interactive technologies in both young children and their caregivers in the context of the need for inhaled medication. Our findings demonstrate that such devices may be of use in encouraging young children to correctly use their inhaler with a facemask and spacer. Improvements and adaptations will need to be made to the device described here based upon the feedback obtained, with the ultimate aim of producing improved devices and applications to improve the technique of use with a paediatric spacer and adherence to treatment. Further studies should assess the potential benefits in terms of improving technique and ultimately in reducing chances of acute exacerbations through maintained adherence and disease control.
